Healthcare
Saudi startup develops AI screening for diabetic eye disease
Saudi startup SDM won second place in a London Business School competition for SAARIA, an AI tool that produces diabetic-eye diagnostic results within minutes without an on-site physician.
Saudi-owned health-tech startup SDM was named runner-up in the London Business School MENA Startup Competition 2026 and received $15,000. Its main product, SAARIA, uses AI to process eye tests and provide diagnostic results within minutes without requiring a physician to be physically present at the examination site. The company developed the technology in response to difficulties faced by diabetic patients seeking specialist eye care, particularly in rural and underserved communities. SDM is also developing AI applications intended to identify early risk indicators associated with hypertension, stroke and Alzheimer’s disease. The company’s approach is therefore focused on screening and earlier intervention rather than only supporting treatment after a diagnosis. The reported use case could help extend specialist diagnostic capacity to locations where ophthalmologists or other clinicians are not readily available. However, the article does not provide clinical-validation results, regulatory approvals or deployment numbers for SAARIA. Its competition recognition indicates commercial and institutional interest in AI-enabled chronic-disease detection, while the broader product roadmap suggests an ambition to apply the technology across several high-burden conditions.
Original source: Arab News